Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. (CRNX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRNX · as of Jun 8, 2026
Key Statistics
Explore Crinetics Pharmaceuticals, Inc. Data
crnx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 100.0%
The CRNX analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $85.83, representing +156.07% upside from the current price of $33.52.
Competitors & Peers
crnx competitorsCRNX
ACAD
AKRO
DYN
IMVT
KYMRStock Performance
Full HistoryAbout Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related…
what is crinetics pharmaceuticals, inc. · crnx stock overview · crinetics pharmaceuticals, inc. company profile · who is crinetics pharmaceuticals, inc. ceo · crnx NASDAQ · crinetics pharmaceuticals, inc. headquarters · crinetics pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Crinetics Pharmaceuticals, Inc. (CRNX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 18, 2018. As of the latest trading session, CRNX stock price is $33.52, with a market capitalization of $3.5B. The stock has returned +1.98% over the past 12 months and -29.28% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Crinetics Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $85.83. In fiscal year 2025, Crinetics Pharmaceuticals, Inc. reported revenue of $7.7M and net income of -$465.3M. For detailed data — including Crinetics Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Crinetics Pharmaceuticals, Inc. (CRNX) stock price is $33.52. The stock is traded on NASDAQ under the ticker symbol CRNX. The 52-week range is $25.83 – $57.99.